Evidence map›Paper›PMID 20350947›Full record

ArticleAntimicrobial agents and chemotherapy2010

ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline.

M Hentschke, M Wolters, I Sobottka, H Rohde, M Aepfelbacher

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A novel mutation ofMicrobiology spectrum · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Dual role ofiMetaOmics · 2024
    Article
  14. Review
  15. Article
  16. Coexistence of blaAnnals of clinical microbiology and antimicrobials · 2024
    Article
  17. Article
  18. The tigecycline resistance mechanisms in Gram-negative bacilli.Frontiers in cellular and infection microbiology · 2024
    Review
  19. Article
  20. Mapping direct and indirect MarA/SoxS/Rob/RamA regulons inMicrobiology (Reading, England) · 2023
    Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M HentschkeInstitute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf,Martinistrasse, Hamburg, Germany. m.hentschke@uke.de
M Wolters
I Sobottka
H Rohde
M Aepfelbacher
Universität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline (MIC, 2 microg/ml) were analyzed. A gene homologous to ramR of Salmonella enterica was identified in Klebsiella pneumoniae. Sequencing of ramR in the nonsusceptible Klebsiella strains revealed deletions, insertions, and point mutations. Transformation of mutants with wild-type ramR genes, but not with mutant ramR genes, restored susceptibility to tigecycline and repressed overexpression of ramA and acrB. Thus, this study reveals a molecular mechanism for tigecycline resistance in Klebsiella pneumoniae.

Indexed as

Genes, BacterialMutationAnti-Bacterial AgentsBacterial ProteinsBase SequenceDNA, BacterialDNA Mutational AnalysisDNA PrimersDrug Resistance, BacterialGene ExpressionHumansIn Vitro TechniquesKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsMinocyclineAnti-Bacterial AgentsBacterial ProteinsDNA, BacterialDNA PrimersMinocyclineRamA protein, KlebsiellaTigecycline

Identifiers

PMID20350947
PMCPMC2876394
OpenAlexW2168549107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.